Northern Trust’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Hold |
71,379
| – | – | ﹤0.01% | 4314 |
|
|
2025
Q1 | $68.1K | Buy |
71,379
+14,743
| +26% | +$14.1K | ﹤0.01% | 4185 |
|
|
2024
Q4 | $103K | Sell |
56,636
-1,111
| -2% | -$2.01K | ﹤0.01% | 4147 |
|
|
2024
Q3 | $83.2K | Hold |
57,747
| – | – | ﹤0.01% | 4102 |
|
|
2024
Q2 | $73.9K | Buy |
57,747
+7,299
| +14% | +$9.34K | ﹤0.01% | 4120 |
|
|
2024
Q1 | $191K | Buy |
50,448
+10,224
| +25% | +$38.6K | ﹤0.01% | 3912 |
|
|
2023
Q4 | $207K | Buy |
40,224
+8,869
| +28% | +$45.7K | ﹤0.01% | 3892 |
|
|
2023
Q3 | $153K | Buy |
31,355
+4,240
| +16% | +$20.7K | ﹤0.01% | 3905 |
|
|
2023
Q2 | $159K | Hold |
27,115
| – | – | ﹤0.01% | 3909 |
|
|
2023
Q1 | $114K | Sell |
27,115
-4,138
| -13% | -$17.3K | ﹤0.01% | 4051 |
|
|
2022
Q4 | $133K | Buy |
31,253
+20,669
| +195% | +$87.8K | ﹤0.01% | 4009 |
|
|
2022
Q3 | $17K | Hold |
10,584
| – | – | ﹤0.01% | 4574 |
|
|
2022
Q2 | $12K | Hold |
10,584
| – | – | ﹤0.01% | 4680 |
|
|
2022
Q1 | $26K | Hold |
10,584
| – | – | ﹤0.01% | 4642 |
|
|
2021
Q4 | $31K | Hold |
10,584
| – | – | ﹤0.01% | 4666 |
|
|
2021
Q3 | $43K | Hold |
10,584
| – | – | ﹤0.01% | 4554 |
|
|
2021
Q2 | $51K | Buy |
+10,584
| New | +$51K | ﹤0.01% | 4494 |
|